Swiss Re AG (SWX:SREN)
149.70
-4.95 (-3.20%)
Aug 8, 2025, 5:31 PM CET
Aerovate Therapeutics Market Cap
Swiss Re AG has a market cap or net worth of 44.72 billion as of August 8, 2025. Its market cap has increased by 45.22% in one year.
Market Cap
44.72B
Enterprise Value
47.96B
Revenue
38.75B
Ranking
n/a
PE Ratio
14.94
Stock Price
$149.70
Market Cap Chart
Since May 2, 1996, Swiss Re AG's market cap has increased from 19.09B to 44.72B, an increase of 134.23%. That is a compound annual growth rate of 2.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 44.72B | 16.86% |
Dec 30, 2024 | 38.27B | 39.37% |
Dec 29, 2023 | 27.46B | 9.89% |
Dec 30, 2022 | 24.99B | -4.20% |
Dec 30, 2021 | 26.08B | 12.21% |
Dec 30, 2020 | 23.25B | -25.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UBS Group AG | 99.77B |
Zurich Insurance Group AG | 82.21B |
Partners Group Holding AG | 29.23B |
Swiss Life Holding AG | 25.29B |
Julius Bär Gruppe AG | 11.64B |
Helvetia Holding AG | 10.98B |
Baloise Holding AG | 9.46B |
Swissquote Group Holding | 8.46B |